Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

714 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
WT1 mutation in 470 adult patients with acute myeloid leukemia: stability during disease evolution and implication of its incorporation into a survival scoring system.
Hou HA, Huang TC, Lin LI, Liu CY, Chen CY, Chou WC, Tang JL, Tseng MH, Huang CF, Chiang YC, Lee FY, Liu MC, Yao M, Huang SY, Ko BS, Hsu SC, Wu SJ, Tsay W, Chen YC, Tien HF. Hou HA, et al. Among authors: huang cf, huang tc, huang sy. Blood. 2010 Jun 24;115(25):5222-31. doi: 10.1182/blood-2009-12-259390. Epub 2010 Apr 5. Blood. 2010. PMID: 20368469 Free article.
Clinically validated machine learning algorithm for detecting residual diseases with multicolor flow cytometry analysis in acute myeloid leukemia and myelodysplastic syndrome.
Ko BS, Wang YF, Li JL, Li CC, Weng PF, Hsu SC, Hou HA, Huang HH, Yao M, Lin CT, Liu JH, Tsai CH, Huang TC, Wu SJ, Huang SY, Chou WC, Tien HF, Lee CC, Tang JL. Ko BS, et al. Among authors: huang tc, huang hh, huang sy. EBioMedicine. 2018 Nov;37:91-100. doi: 10.1016/j.ebiom.2018.10.042. Epub 2018 Oct 22. EBioMedicine. 2018. PMID: 30361063 Free PMC article. Clinical Trial.
ASXL1 mutation confers poor prognosis in primary myelofibrosis patients with low JAK2V617F allele burden but not in those with high allele burden.
Wang YH, Lin CC, Lee SH, Tsai CH, Wu SJ, Hou HA, Huang TC, Kuo YY, Yao M, Chang K, Lin CW, Lin YC, Tien FM, Chou WC, Tang JL, Tien HF. Wang YH, et al. Among authors: huang tc. Blood Cancer J. 2020 Oct 12;10(10):99. doi: 10.1038/s41408-020-00364-5. Blood Cancer J. 2020. PMID: 33046688 Free PMC article. Clinical Trial. No abstract available.
Polatuzumab vedotin-based salvage immunochemotherapy as third-line or beyond treatment for patients with diffuse large B-cell lymphoma: a real-world experience.
Wang YW, Tsai XC, Hou HA, Tien FM, Liu JH, Chou WC, Ko BS, Chen YW, Lin CC, Cheng CL, Lo MY, Lin YC, Lu LC, Wu SJ, Kuo SH, Hong RL, Huang TC, Yao M. Wang YW, et al. Among authors: huang tc. Ann Hematol. 2022 Feb;101(2):349-358. doi: 10.1007/s00277-021-04711-9. Epub 2021 Nov 11. Ann Hematol. 2022. PMID: 34766217 Clinical Trial.
Clinical manifestations and risk factors for COVID-19 and its severity in patients with hematological malignancies.
Wu TY, Tsai WT, Chen KH, Huang ST, Huang CF, Kuo PH, Tsai MJ, Liu WD, Lin KY, Huang YS, Cheng A, Chen PY, Sun HY, Huang HH, Huang TC, Wu SJ, Yao M, Wang JT, Sheng WH, Hung CC, Chen YC, Chang SC. Wu TY, et al. Among authors: huang tc. J Microbiol Immunol Infect. 2024 Mar 8:S1684-1182(24)00047-1. doi: 10.1016/j.jmii.2024.03.001. Online ahead of print. J Microbiol Immunol Infect. 2024. PMID: 38480093 Free article.
714 results